Marimed (MRMD) Change in Accured Expenses (2011 - 2026)

Marimed (MRMD) has 16 years of Change in Accured Expenses data on file, last reported at $829000.0 in Q1 2026.

• On a quarterly basis, Change in Accured Expenses fell 56.09% year-over-year to $829000.0 in Q1 2026; TTM through Mar 2026 was $2.1 million, a 17.56% decrease from a year earlier, with the FY2025 full-year figure at $3.2 million, up 80.27% from the prior year.
• Change in Accured Expenses for Q1 2026 stood at $829000.0, up from $259000.0 in the prior quarter.
• Over the last five years, Change in Accured Expenses for MRMD reached as high as $1.9 million in Q1 2025 and fell as low as -$1.7 million in Q4 2023.
• Historically, Change in Accured Expenses has averaged $201352.9 across 5 years, with a median of -$136000.0 in 2024.
• Across the five-year window, Change in Accured Expenses plunged 845.83% in 2022 and surged 627.05% in 2024, its largest moves.
• Year by year, Change in Accured Expenses stood at -$289000.0 in 2022, then plunged by 491.0% to -$1.7 million in 2023, then jumped by 39.58% to -$1.0 million in 2024, then jumped by 125.1% to $259000.0 in 2025, then surged by 220.08% to $829000.0 in 2026.
• Per Business Quant data, the three most recent Change in Accured Expenses figures were $829000.0 in Q1 2026, $259000.0 in Q4 2025, and $1.3 million in Q3 2025.